JAZZ

Jazz Pharmaceuticals plc (Ireland) (JAZZ)

About Jazz Pharmaceuticals plc (Ireland) (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$124.39

Daily low

$121.37

Price at open

$122.85

52 Week High

$134.17

52 Week Low

$99.06

Market cap

7.4B

Dividend yield

0.00%

Volume

1.8M

Avg. volume

632,435

P/E ratio

17.71

Jazz Pharmaceuticals plc (Ireland) News